Author:
Walker Evan J.,Carnevale Julia,Pedley Christina,Blanco Amie,Chan Salina,Collisson Eric A.,Tempero Margaret A.,Ko Andrew H.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics(clinical),Oncology,Genetics
Reference42 articles.
1. Peters ML, Tseng JF, Miksad RA (2016) Genetic testing in pancreatic ductal adenocarcinoma: implications for prevention and treatment. Clin Ther 38(7):1622–1635.
https://doi.org/10.1016/j.clinthera.2016.03.006
2. Shindo K, Yu J, Suenaga M, Fesharakizadeh S, Cho C, Macgregor-Das A, Siddiqui A, Witmer PD, Tamura K, Song TJ, Navarro Almario JA, Brant A, Borges M, Ford M, Barkley T, He J, Weiss MJ, Wolfgang CL, Roberts NJ, Hruban RH, Klein AP, Goggins M (2017) Deleterious germline mutations in patients with apparently sporadic pancreatic adenocarcinoma. J Clin Oncol 35(30):3382–3390.
https://doi.org/10.1200/jco.2017.72.3502
3. Lowery MA, Wong W, Jordan EJ, Lee JW, Kemel Y, Vijai J, Mandelker D, Zehir A, Capanu M, Salo-Mullen E, Arnold AG, Yu KH, Varghese AM, Kelsen DP, Brenner R, Kaufmann E, Ravichandran V, Mukherjee S, Berger MF, Hyman DM, Klimstra DS, Abou-Alfa GK, Tjan C, Covington C, Maynard H, Allen PJ, Askan G, Leach SD, Iacobuzio-Donahue CA, Robson ME, Offit K, Stadler ZK, O’Reilly EM (2018) Prospective evaluation of germline alterations in patients with exocrine pancreatic neoplasms. J Natl Cancer Inst.
https://doi.org/10.1093/jnci/djy024
4. NCCN Clinical Practice Guidelines in Oncology: Pancreatic cancer, version 2.2018
https://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf
. Accessed 16 Sept 2018
5. NCCN Clinical Practice Guidelines in Oncology: Genetic/familial high-risk assessment (breast and ovarian), version 2.2019
https://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf
. Accessed 16 Sept 2018
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献